Centro de Investigación Pergamino S.A

Buenos Aires 2700

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma

Studies at this site

• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early